Scandi Standard

Legger ut en link til en emisjon i Sverige som er tilgjengelig via Nordnet også for norske kunder. Det gjelder Scandi Standard som er Skandinavias ledende selskap for kyllingbaserte produkter noe som inkluderer Den stolte Hane i Norge.

Minstetegning kr. 300 maks kr.20.000. Tegningsfrist 25.06.2014.


https://www.nordnet.no/kampanjer/IPO/scandistandard.html?cmpe=mail-no

Havyard Group ASA

Havyard Group ASA ønsker å noter seg på Oslo Børs, men de nøyer seg med Axess hvis de må noe som er en vanlig forutsetning. De får hjelp av Fearnley og Arctic i prosessen. Retail rabatt på 1.500 kr og minimum tegning på 10.800. Tegningsfristen er 24.06.2014 kl.12.

Selskapet er fra Fosnavåg i Norge med kontorer i Polen og Kroatia og salgskontorer i Kina og Brasil.

Om businessen: Havyard Group is a group of companies whose principal business is to deliver ship designs, ship equipment and activities construction of advanced vessels for offshore oil service, fishing and fish farming for shipyards and shipowners worldwide. Havyard Group delivers products and services within the complete value chain from vessel design to support of vessels in operation.

Prospekt: http://www.arcticsec.no/offerings_doc/Havyard_Group_ASA/disc1.htm

Hjemmeside: http://www.havyard.com/

Next Biometrics Group ASA

Next Biometrics Group ASA skal på Oslo Axess og får hjelp av Arctic Securities ASA og Carnegie AS. Ingen retail rabatt. Bøkene stenges kl.12 19.06.2014.

De driver med fingavtrykksensorer, som ligner det man har på iPhone 5s.

Om businessen:

The Group is a provider of fingerprint sensors. The business of the Group consists of research & development, commercialization and manufacturing of fingerprint technology and products for a variety of uses, including smartphones, tablets, smart card readers, portable hard drives, safety boxes, voting machines, card readers and physical entrances.

The Company has developed a number of fingerprint sensor modules which may be incorporated into a wide range of products and solutions. The key feature of the fingerprint sensors developed by the Group is that it uses a unique and patented principle of thermal conductivity which allows mass production at a significantly lower cost of comparable competitors.

 

The Group has entered into agreements with KOEHLKE and a major Beijingbased system integrator based on delivered prototypes. Both companies have received integration units for the first line of their products. On 23 April 2014 the Group entered into an updated supply agreement with KOEHLKE. Pursuant to the supply agreement, KOEHLKE is obliged to purchase 100,000 sensors in 2014, 900,000 sensors in 2015 and 3,000,000 sensors in 2016. A first purchase order of 53,000 units to be delivered in 2014 has already been placed.

On 15 May 2014, the Company received a purchase order for 10,000 units from a second Chinese sensor system integrator. The integrator is a new partner with the Company and is a leading supplier within existing (traditional markets) segments of the Chinese market, including sensor units for time and attendance and physical access control. The sensors are to be delivered in 2014.

As of the date of the Prospectus, the Group had 26 employees.

 

Prospekt: http://www.arcticsec.no/offerings_doc/NEXT_Biometrics_Group/disc1.htm

 

Hjemmside: http://nextbiometrics.com/

 

 

Hengar hadde en artikkel om at emisjonen allerede er overtegnet den 11.06.2013.

http://www.hegnar.no/bors/artikkel506351.ece

Zalaris ASA

Zalaris vil på Oslo Børs ved hjelp av ABG Sundal Collier og Nordea Markets. Retail rabatt på 1.500 og minstetegning på 10.500. Green shoe. Tegningsfrist 18.06.2014 kl.12.

Selskapet er norskt og driver med Human Resources Outsourcing (HR)O i Norden, Baltikum og Polen hovedsakelig. Det er eid av et PE fond. De er gode til å regne og gir sjeldent fra seg mer enn de må.

 

 

 

Om businessen:

Zalaris is a provider of Human Resources Outsourcing (HRO) services to large corporate clients in the Nordics, Baltics and Poland. Specifically, Zalaris uses SAP’s Human Capital Management (HCM) platform as their preferred software to power HRO solutions to their customers, delivered on a  Software as a Service‖ (―SaaS‖) Cloud based model.

Zalaris’ services include maintaining employee master data, payroll processing, handling of travel & expenses, time & absence administration, recruitment management and administration of employee benefits such as pension, insurance, telephone, subscriptions and other items. Based on a common web and mobile technology platform, Zalaris is able to capture relevant payroll data at source in a standardised process for all clients. Through the utilisation of best-practice processes, supported by SAP’s web based Employee Self Service and Manager Self Service the Group aims to reduce and ―variabilise‖ the client’s transactional HR process costs.

Zalaris also offers a cloud-based solution for talent management such as e-learning, performance reviews, competency management, succession planning and HR analytics based on SuccessFactors, a SAP solution. In addition to the outsourcing division,

Zalaris also supports customers with own on-premise solutions through their consulting unit. The consulting division offers full service implementation of SAP HCM and SuccessFactors functionality for clients including pre-study, blueprint/design, configuration, testing, migration and go-live support.

Zalaris’ vision is to become the leading European provider of outsourced payroll, HR and consulting services by helping their clients reaching the maximal value of their Human Resources through best-practice HR processes.

The Group is headquartered in Oslo, Norway. Zalaris today has service centres in Norway, Sweden, Denmark, Finland, Latvia, Lithuania, Poland and India where they speak the local language and offers in-depth knowledge on local laws and regulations. In total, the Group has c. 370 employees, serving a portfolio of over 40 BPO customers across several industries, with more than 150,000 employees being served each month.

 

Prospekt: https://www.abgsc.com/PageFiles/400/Zalaris%20ASA%20-%20Prospectus%2005.06.2014.pdf?epslanguage=en

 

Hjemmside: http://www.zalaris.com/

Nordcap Offshore Inc.

Oppdatering: De lykkes ikke med kapitalinnhentingen og børsnoteringen er avlyst.

Nordcap Offshore Inc. får hjelp av Arctic Securities ASA og RS Platou Markets AS med å bli notert på Oslo Axess.

Ingen retail rabatt. Green shoe. Minstetegning 10.000. Tegningsfrist 17.06.2014 kl.12.

 PSV (ikke tilknyttet Nordcap).

Selskapet er registrert på Marshall øyene, men har utspring i fra Tyskland og er etablert i 2014. De driver innen supply med fokus på PSV skip.

Om businessen:

The Group’s business strategy is to profitably grow the business and act as a successful owner and operator of modern offshore supply vessels ("OSVs") with an initial focus on mid to large sized platform supply vessels ("PSVs"). PSVs are used for transporting supplies and equipment to and from offshore installations such as drilling rigs, drilling platforms or drilling vessels. The Group’s initial focus of operations will be in the North Sea and Africa.

At the date of the Prospectus, the Group does not own a fleet of PSVs but it intends to use the proceeds of the Offering to fund the equity portion for the acquisition of 10 (ten) mid to large sized PSVs planned to be fully delivered within May 2016 (the "Initial Fleet"). This Initial Fleet will consist of 2 (two) second-hand vessels built in 2008 which are owned by E.R. Capital Holding GmbH & Cie KG ("E.R. Capital Holding") and fully operational. The remaining 8 (eight) vessels are newbuildings from reputable designers currently under construction in Asia. The last vessel of the Initial Fleet is scheduled to be delivered ex yard by May 2016.

Prospekt:

http://www.arcticsec.no/offerings_doc/Nordcap_Offshore_Inc/disc1.htm

Hjemmeside:

http://www.nordcap-offshore.com/

Serendex Pharmaceut​icals A/S

Serendex skal på noteres på Oslo Axess. Selskapet frontes av Norne Securities med støtte i fra Netfonds. Det tilbys en retail rabatt på 1.500 og minste tegningsbeløp er 10.500. Tegningsfristen er 20.06.2014 kl. 12.00.

Om businessen:
Serendex is a pharmaceutical company dedicated to the development of new, effective treatments for serious lung diseases that do not respond to best current therapeutic practice. By repositioning well-nown, existing drugs that have a limited use within their current indications, Serendex seeks to meet this medical need. The current pipeline focuses on the following seven indications:
• Molgradex® for the treatment of pulmonary alveolar proteinosis (PAP)
• Molgradex® for the treatment of cystic fibrosis (CF) lung infections
• Molgradex® for the treatment of lung infections in non-cystic-fibrosis bronchiectasis (BE)
• Molgradex® for the treatment of acute respiratory distress syndrome (ARDS) and ventilator-requiring lung infection (“VAP”)
• APC: recombinant human activated protein C OR TFPI: recombinant human tissue factor pathway inhibitor for the treatment of acute respiratory distress syndrome (ARDS) and acute lung injury (ALI)
• FVIIa: recombinant human factor VIIa (eptacog alfa (activated)) for the treatment of diffuse alveolar hemorrhage (DAH)
• Fosfomycin: inhaled fosfomycin for the treatment of lung infections with antibiotic-resistant organisms.

Prospekt:
http://www.netfonds.no/tegning.php?page=SERE-PRO

Selskapet:
http://www.serendex.com/

En blogg om nynoteringer på Oslo Børs

Oppretter en blogg som erstatning for maillisten om nynoteringer på Oslo Børs. Tror det blir enklere å se historikken, komme med innspill og evenuelt påføre oppdateringer.

Det er morro at det skjer en del på Børsen. Og det er også muligheter til å tjene litt penger.

Kom gjerne med innspill hvis du har noen.